179 related articles for article (PubMed ID: 29597169)
1. Synthesis and evaluation of novel coumarin-oxime ethers as potential anti-tubercular agents: Their DNA cleavage ability and BSA interaction study.
Reddy DS; Kongot M; Netalkar SP; Kurjogi MM; Kumar R; Avecilla F; Kumar A
Eur J Med Chem; 2018 Apr; 150():864-875. PubMed ID: 29597169
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies.
Reddy DS; Hosamani KM; Devarajegowda HC
Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents.
Fan YL; Wu JB; Ke X; Huang ZP
Bioorg Med Chem Lett; 2018 Oct; 28(18):3064-3066. PubMed ID: 30119957
[TBL] [Abstract][Full Text] [Related]
4. A click chemistry approach for the synthesis of mono and bis aryloxy linked coumarinyl triazoles as anti-tubercular agents.
Anand A; Naik RJ; Revankar HM; Kulkarni MV; Dixit SR; Joshi SD
Eur J Med Chem; 2015 Nov; 105():194-207. PubMed ID: 26491982
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
Penta A; Franzblau S; Wan B; Murugesan S
Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.
Kawate T; Iwase N; Shimizu M; Stanley SA; Wellington S; Kazyanskaya E; Hung DT
Bioorg Med Chem Lett; 2013 Nov; 23(22):6052-9. PubMed ID: 24103299
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
[TBL] [Abstract][Full Text] [Related]
8. Recent developments of coumarin-containing derivatives and their anti-tubercular activity.
Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS
Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250
[TBL] [Abstract][Full Text] [Related]
9. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Investigation of Phthalazinones as Antitubercular Agents.
Santoso KT; Cheung CY; Hards K; Cook GM; Stocker BL; Timmer MSM
Chem Asian J; 2019 Apr; 14(8):1278-1285. PubMed ID: 30680937
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, molecular docking, and biological evaluation of coumarin-thymidine analogs as potent anti-TB agents.
Reddy DS; Sinha A; Kurjogi MM; Shanavaz H; Kumar A
Arch Pharm (Weinheim); 2023 May; 356(5):e2200633. PubMed ID: 36634969
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of natural and synthetic coumarin derivatives against
Pires CT; Scodro RB; Cortez DA; Brenzan MA; Siqueira VL; Caleffi-Ferracioli KR; Vieira LC; Monteiro JL; Corrêa AG; Cardoso RF
Future Med Chem; 2020 Sep; 12(17):1533-1546. PubMed ID: 32820960
[No Abstract] [Full Text] [Related]
15. 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents.
Siddiqui AB; Trivedi AR; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2014 Mar; 24(6):1493-5. PubMed ID: 24582983
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-tubercular activity of novel alkyl substituted riminophenazine derivatives.
Li YL; Zhang CL; Zhang DF; Lu Y; Wang B; Zheng MQ; Li C; Yin DL; Huang HH
Yao Xue Xue Bao; 2012 Jun; 47(6):745-54. PubMed ID: 22919722
[TBL] [Abstract][Full Text] [Related]
17. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
[TBL] [Abstract][Full Text] [Related]
18. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y
Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
20. 3-benzylidene-4-chromanones: a novel cluster of anti-tubercular agents.
Das U; Lorand T; Dimmock SG; Perjesi P; Dimmock JR
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):259-63. PubMed ID: 24939095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
